Clinician Link.AI ™️’s Post

🎥 Explore the new frontier in anti-VEGF therapies with Dr. John Kitchens (RETINA ASSOCIATES OF KENTUCKY) as he compares the newer generation, including faricimab and Bayer | Ophthalmology 8 mg aflibercept, to older medications. Discover how Bayer | Ophthalmology Eylea HD (8 mg aflibercept) is revolutionizing treatment, allowing for fewer injections and extended treatment intervals, providing significant benefits for patients. Dr. Kitchens delves into the advantages of these advancements and how they're enhancing patient care in ophthalmology. Join us to learn how these innovations are changing the game! #COPHY2024 #EyleaHD #AntiVEGF #OphthalmologyInnovation #Aflibercept8mg #PatientCareProgress #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation #Surgicalretina  COPHy Congress Simrat Sodhi

🌟👁️ Discover the clinical advantages of high-dose EYLEA® HD (aflibercept) Injection HCP through the experiences of Drs. Kenneth Fan, Sherveen Salek, and David Brown. In a compelling series of interviews, these experts discuss the effectiveness of this treatment in managing severe retinal diseases, sharing their successes in transforming patient outcomes. Learn more about the potent impact of high-dose Eylea on ophthalmic care. #ASRS2024 #Ophthalmology #MedicalLeadership #VisionaryInOphthalmology #MedicalInnovation #RetinaSpecialists #EyeCareInnovation #VisionScience #MedTech #HealthcareTrends #ClinicalResearch ASRS – American Society of Retina Specialists Bayer Bayer | Ophthalmology

I'm excited to share my recent experience using the new Streamline Viscocanaloplasty System from New World Medical in combination with the iStent Infinite from Glaukos for glaucoma management. This innovative approach has been instrumental in decreasing intraocular pressure (IOP) and reducing the medication burden for our patients. In the procedure, the Streamline system injects viscoelastic into Schlemm's canal, enhancing aqueous outflow. The attached video vividly demonstrates this process, showing viscoelastic and blood refluxing out of an iStent ostium as the viscoelastic is introduced. This visual evidence underscores the efficacy of combining these technologies to improve patient outcomes. Embracing such advancements allows us to offer better care and improve the quality of life for those affected by glaucoma. I'm looking forward to continuing to explore and implement cutting-edge solutions in ophthalmology. #GlaucomaManagement #InterventionalGlaucoma #OphthalmologyInnovation #PatientCare #Glaukos #NewWorldMedical #eyeassociatesofsouthtexas #jtkavanaghmd #streamline #istentinfinite #synergy

🌐👁️ Dive into the future of patient care with Dr. Rufino Silva at European Society of Retina Specialists (EURETINA) 2024! Dr. Silva shares groundbreaking insights on leveraging OCT and mobile technology to enhance patient monitoring. From detecting subtle changes with apps at home to utilizing peripheral OCT in clinics, these innovations aim to reduce clinic visits while ensuring effective management of conditions like PCV. 📱🔍 Discover how these technologies not only ease the treatment burden but also improve the precision in monitoring disease progression. Dr. Silva highlights the efficacy of EYLEA® HD (aflibercept) Injection HCP 8mg in delivering both anatomical and functional improvements for patients. 🎥 Stay tuned as Dr. Silva elaborates on the integration of advanced biomarkers and technology in ophthalmology, paving the way for more personalized and efficient patient care. #Euretina #Ophthalmology #EyeCare #RetinaSpecialist #MedicalInnovation #VisionHealth #EyeHealth #DigitalHealth #Retina #Ophthalmology #ClinicianLinkLive  Bayer Bayer | Ophthalmology

👁️🔬 Dr. David Eichenbaum shares groundbreaking findings from his study on aflibercept high dose (EYLEA® HD (aflibercept) Injection HCP 8mg) in treating wet AMD. As the first real-world data set, the study reveals that while a significant portion of patients responded positively, extending treatment intervals, a segment still required more frequent care. This pivotal research highlights the importance of personalized medicine in ophthalmology, as responses vary widely among patients. Discover more about how these insights are shaping future treatment protocols. #ASRS2024 #Ophthalmology #MedicalLeadership #VisionaryInOphthalmology #MedicalInnovation #RetinaSpecialists #EyeCareInnovation #VisionScience #MedTech #HealthcareTrends #ClinicalResearch ASRS – American Society of Retina Specialists Bayer Bayer | Ophthalmology Saghar Bagheri MD PhD

🎥 Join Dr. John Kitchens (RETINA ASSOCIATES OF KENTUCKY) as he discusses the remarkable impact of Bayer | Ophthalmology aflibercept 8 mg in reducing the number of injections over two years. Discover how this advancement not only equates to cost neutrality compared to existing therapies but also offers significant benefits for the healthcare system by decreasing the frequency of examinations and imaging. Dive into the conversation to understand how aflibercept 8 mg is transforming patient care by offering less frequent treatments while maintaining effectiveness. #COPHY2024 #EyleaHD #AntiVEGF #OphthalmologyInnovation #Aflibercept8mg #PatientCareProgress #OphthalmologyResearch #PatientCare #HealthcareEducation #retina #OphthalmologyFuture #medicalinnovation  COPHy Congress Simrat Sodhi

🌐🔬 From double-digit injections to potentially just a couple a year—join Dr. Prof. Marion Munk, M.D., Ph.D at European Society of Retina Specialists (EURETINA) 2024 as she delves into the transformative landscape of anti-VEGF therapy. Dr. Munk shares insights on how advancements in drug development are not only reducing the frequency of treatments but are also broadening the horizon with new modes of action targeting various aspects of retinal diseases. 💡👀 Explore how the shift towards drugs that address additional vascular endothelial growth factors and tackle underlying degenerative processes promises a future where treatments are not only longer-lasting but also more comprehensive. 🎙️ Stay tuned as we continue to bring you the latest groundbreaking discussions from the forefront of ophthalmology. #Euretina #Ophthalmology #EyeCare #RetinaSpecialist #MedicalInnovation #VisionHealth #EyeHealth #DigitalHealth #Retina #Ophthalmology #ClinicianLinkLive 

Our Medical Advisor, Theodore Leng, MD, MS, will head to Sweden next week to present results from the FARETINA-DME Study at the ASRS Annual Meeting. The study analyzes #RWD from the American Academy of Ophthalmology IRISⓇ Registry (Intelligent Research in Sight) to identify the 12-month real-world clinical and anatomical outcomes with #faricimab in patients with diabetic macular edema. https://hubs.la/Q02G9Fcz0 #DME #rwd #rwe

I'm pleased to announce our latest study published in International Ophthalmology: "Canaloplasty via an ab-interno surgical technique in patients with primary angle-closure glaucoma (PACG)." Our findings highlight ab-interno canaloplasty as a safe and effective approach for #PACG—a glaucoma type traditionally not indicated for MIGS procedures. In PACG, canaloplasty achieved significant reductions in intraocular pressure (IOP) and lowered medication reliance, presenting an encouraging management option for this challenging glaucoma type. These findings may be particularly relevant for clinicians in Asia, where angle-closure glaucoma is more prevalent. For those interested in the details, I invite you to explore our research here: https://lnkd.in/db5ym4CX #GlaucomaResearch #Canaloplasty #MIGS #Ophthalmology #PACG #EyeCare #ClinicalOutcomes #glaucoma #angleclosure Springer Nature

Greater long-term blood pressure (BP) variability is associated with faster visual field loss, especially for patients with high mean BP and intraocular pressure (IOP), according to a JAMA Ophthalmology report. The study’s authors suggest that blood pressure variability may be a modifier of the association between IOP and visual field loss in patients in glaucoma. Read here: https://bit.ly/3YWCs2w #BloodPressure #BPVariability #VisualFieldLoss #VisualField #IntraocularPressure #IOP #Glaucoma #Ophthalmology #EyeHealth #EyeCare #Ophthalmologist